Page 225 - PROGRAMME2018

P-207 Embryo secretome profile from infertile patients undergoing assisted reproductive techniques can be affected by infertility factors
T. Bonetti1, D. Hadad2, T. Domingues1,3, J.R. Alegretti4, E. Motta1,3, K. Seeley5, I. Silva1
1Universidade Federal de Sao Paulo - Escola Paulista de Medicina UNIFESP-EPM, Gynecology, São Paulo- SP, Brazil
2Universidade Federal de Sao Paulo - Escola Paulista de Medicina UNIFESP-EPM, Urology, São Paulo- SP, Brazil
3Huntington Centro de Medicina Reprodutiva, Clinical, Sao Paulo, Brazil 4Huntington Centro de Medicina Reprodutiva, Embryology, Sao Paulo, Brazil
5University of South Florida, Proteomics and Mass Spectrometry Facility- Center for Drug Discovery and Innovation CDDI, Tampa, U.S.A.
P-208 Oviduct-embryo interaction in cattle: Effect of asynchrony between the embryo and the oviduct on subsequent embryo development
B. Rodriguez Alonso1, J.M. Sánchez1, M. Hamdi2, U. Besenfelder3, V. Havlicek3, P. Lonergan1, D. Rizos2 1University College Dublin UCD, School of Agriculture and Food Science, Dublin, Ireland
2National Institute for Agriculture and Food Research and Technology INIA, Animal Reproduction, Madrid, Spain
3University of Veterinary Medicine, Biomedical Sciences, Vienna, Austria
P-209 Laboratory and clinical outcome with embryos cultured in continuous single step media containing reduced lactate: A prospective sibling oocyte study
T. Aksoy1, N. Findikli1, B. Ozturk1, I.O. Olcay1, F.K. Boynukalin2, E. Oral3, M. Bahceci2
1Bahceci Fulya IVF Centre, IVF Laboratory, Istanbul, Turkey
2Bahceci Fulya IVF Centre, Infertility Clinic, Istanbul, Turkey
3Istanbul University Cerrahpasa School of Medicine, Obstetrics and Gyneocology, Istanbul, Turkey
P-210 Spindle transfer can enhance the potential of developmentally compromised human oocytes to reach the blastocyst stage: proof of concept with donor oocytes
N. Costa-Borges1, E. Nikitos2, I. Miguel-Escalada, K. Rink1, K. Spath3, D. Wells4,
I. Zervomanolakis2, I. Vasilopoulos2, D. De Ziegler, S. Grigorakis2, G. Kontopoulos2, T. Prokopakis2, K. Dimitropoulos2, P. Polyzos, N. Vlachos2, K. Kostaras2, P. Psathas2, G. Calderón1
1Embryotools S.L., Embryotools, Barcelona, Spain
2Institute of Life, IVF center, Athens, Greece
3CooperGenomics, CooperGenomics, Oxford, United Kingdom
4University of Oxford, Nuffield Department of Women's and Reproductive Health, Oxford, United Kingdom
FINAL PROGRAMME I BARCELONA, SPAIN – 1 TO 4 JULY 2018 225
POSTERS